Yeji

$BCAB

BioAtla, Inc.

Runway:1 mo
NasdaqMarket cap: —CIK 0001826892

Upcoming catalysts

0 surfaced

No catalysts surfaced for BCAB yet.

Drug pipeline

CAB-ROR2-ADC
Non Small Cell Lung Cancer
CAB-AXL-ADC
Undifferentiated Pleomorphic Sarcoma
BA3182
Advanced Adenocarcinoma
Ozuriftamab Vedotin
Head and Neck Cancer
BA3071
NSCLC

Recent & active trials

NCTDrugPhaseStatusPrimary completion
NCT05808634BA3182Phase 1Recruiting2028-09-15
NCT05271604Ozuriftamab VedotinPhase 2Completed2025-09-22
NCT04681131CAB-AXL-ADCPhase 2Completed2025-07-09
NCT05180799BA3071Phase 2Active Not Recruiting2025-03-19
NCT03425279CAB-AXL-ADCPhase 2Completed2025-01-08
NCT03504488CAB-ROR2-ADCPhase 2Completed2024-12-30